{{Rsnum
|rsid=3117582
|Gene=BAT3
|Chromosome=6
|position=31652743
|Orientation=minus
|GMAF=0.03857
|Gene_s=BAG6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 85.0 | 14.2 | 0.9
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 92.5 | 6.8 | 0.7
| ASW | 94.7 | 5.3 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 97.3 | 2.7 | 0.0
| MEX | 94.8 | 5.2 | 0.0
| MKK | 90.4 | 9.6 | 0.0
| TSI | 87.3 | 12.7 | 0.0
| HapMapRevision=28
}}{{PMID|18978787|OA=1
}} [[lung cancer]] [[rs3117582]] P = 4.97 x 10(-10)

{{omim
|desc=LUNG CANCER SUSCEPTIBILITY 4; LNCR4
|id=612593
|rsnum=3117582
}}
{{PMID Auto
|PMID=19654303
|Title=Deciphering the Impact of Common Genetic Variation on Lung Cancer Risk: A Genome-Wide Association Study
|OA=1
}}

{{PMID Auto GWAS
|PMID=19836008
|Trait=Lung adenocarcinoma
|Title=A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
|RiskAllele=C
|Pval=5E-12
|OR=1.22
|ORtxt=[1.15-1.29]
|OA=1
}}

{{PharmGKB
|RSID=rs3117582
|Name_s=
|Gene_s=APOM, BAT3
|Feature=
|Evidence=PubMed ID:18978787; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=Common 5p15.33 and 6p21.33 variants influence lung cancer risk. (Initial Sample Size: 1,952 cases, 1,438 controls; Replication Sample Size: 7,579 cases, 8,236 controls); (Region: 6p21.33; Reported Gene: BAT3MSH5; Risk Allele: rs3117582-C) This variant is associated with Lung cancer.
|Drugs=
|Drug Classes=
|Diseases=Lung Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740872
}}

{{PMID Auto
|PMID=20142248
|Title=Cumulative effect of multiple Loci on genetic susceptibility to familial lung cancer
|OA=1
}}

{{PharmGKB
|RSID=rs3117582
|Name_s=
|Gene_s=APOM, BAT3
|Feature=
|Evidence=PubMed ID:18978787
|Annotation=In a GWAS this variant 6p21.33 was associatd with lung cancer risk.
|Drugs=
|Drug Classes=
|Diseases=Lung Neoplasms
|Curation Level=Curated
|PharmGKB Accession ID=PA162360100
}}

{{PharmGKB
|RSID=rs3117582
|Name_s=
|Gene_s=APOM, BAT3
|Feature=
|Evidence=PubMed ID:18978787; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Common 5p15.33 and 6p21.33 variants influence lung cancer risk. (Initial Sample Size: 1,952 cases, 1,438 controls; Replication Sample Size: 7,579 cases, 8,236 controls); (Region: 6p21.33; Reported Gene(s): BAT3,MSH5; Risk Allele: rs3117582-C); (p-value= 0.0000000005).This variant is associated with Lung cancer.
|Drugs=
|Drug Classes=
|Diseases=Lung Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740765
}}

{{PMID|19423719|OA=1
}} Update in lung cancer 2008.

{{PMID|19474294|OA=1
}} Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

{{PMID|19955392}} Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.

{{PMID Auto
|PMID=25231575
|Title=Susceptibility to large-joint osteoarthritis (hip and knee) is associated with BAG6 rs3117582 SNP and the VNTR polymorphism in the second exon of the FAM46A gene on chromosome 6
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}